The global
photon counting computed tomography (PCCT) marketv is set to
witness a CAGR of ~20% in the next 5 years. Superior image quality
and resolution, radiation dose reduction aided by PCCT, rising burden of
chronic diseases, technological advancements and AI integration, and increased
research and clinical validation are some of the key factors driving the photon
counting CT market.
Photon-counting computed tomography (PCCT) is a novel
technology that allows higher spatial resolution as compared to conventional CT
techniques resulting in improved spatial resolution, enhanced tissue contrast,
and minimized image noise while retaining energy specific information. Compared
to conventional CT, it provides similar dose reduction, specific material
differentiation, and reduced contrast resolution; making it highly desirable
for advanced imaging of diagnostic value in oncology, cardiology, and neurology
areas. Overall photon counting CT represents a significant leap in diagnostic
imaging technology.
Click here to get our sample PDF report for Medical
Devices market:
https://meditechinsights.com/photon-counting-computed-tomography-market/request-sample/
Superior image quality and resolution to drive market
growth
The ability to provide superior image quality and resolution
is a key factor contributing to the growth of the PCCT market because it will
significantly improve diagnostic accuracy. PCCT technology utilizes advanced
detectors that count individual X-ray photons and store their energy
information. This yields greater spatial resolution and improved
contrast-to-noise ratio compared to conventional CT systems, resulting in the
superior depiction of small anatomical structures and subtle lesions, which is
valuable when detecting early-stage cancers, cardiovascular abnormalities, and
neurological disorders. The use of photon counting CT is likely to become more
prevalent in clinical practice because of its ability to provide sharper and
more defined images compared to conventional systems, thereby improving patient
care, patient outcomes, and clinical confidence.
Increased research and clinical validation to boost
market growth
Various large medical imaging device manufacturers like
Siemens Healthineers, GE HealthCare, and Canon Medical Systems among others are
realizing the transformative potential of the technology and hence actively
investing in or developing PCCT systems. For instance, in 2021, Siemens
Healthineers launched and received FDA approval for its Naeotom Alpha, world’s
first commercially approved PCCT system, thus setting a benchmark and opening
the market. In 2024, Canon Medical Systems Corporation and Canon Healthcare
USA, Inc. entered into a research collaboration with Penn Medicine for speeding
the development of PCCT. In 2020, GE Healthcare acquired Prismatic Sensors, a
Swedish start-up company having expertise in photon counting detectors, to
strengthen their position in this market. The increased participation by both
established and new imaging companies is a major contributor to the growth of
the PCCT market, as it is driving innovation, increasing accessibility and
moving photon counting CT from a research innovation to a mainstream diagnostic
modality.
Competitive Landscape Analysis
The global photon counting CT market is marked by the
presence of established and emerging market players such as Siemens
Healthineers AG; GE Healthcare; Canon Medical Systems Corporation;
Koninklijke Philips N.V.; Shanghai United Imaging Healthcare Co., LTD;
Samsung; and Hitachi; among others. Some
of the key strategies adopted by market players include new product
development, strategic partnerships and collaborations, and geographic
expansion.
Get PDF Report for Competitive Analysis:
https://meditechinsights.com/photon-counting-computed-tomography-market/request-sample/
Global Photon Counting Computed Tomography (CT) Market
Segmentation
This report by Medi-Tech Insights provides the size of
the global photon counting CT market at the regional- and country-level
from 2023 to 2030. The report further segments the market based on type,
application, and end user.
Market Size & Forecast (2023-2030), By Technology,
USD Million
- Single
Detector PCCT
- Dual-Detector
PCCT
- Multidetector
PCCT
Market Size & Forecast (2023-2030), By Application,
USD Million
- Oncology
- Cardiology
- Neurology
- Pulmonology
- Others
Market Size & Forecast (2023-2030), By End User, USD
Million
- Hospitals
- Diagnostic
Imaging Centers
- Others
Market Size & Forecast (2023-2030), By Region, USD
Million
- North
America
- US
- Canada
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Rest
of Europe
- Asia
Pacific
- China
- India
- Japan
- Rest
of Asia Pacific
- Latin
America
- Middle
East & Africa
Medi-Tech Insights
is a healthcare-focused business research & insights firm. Our clients
include Fortune 500 companies, blue-chip investors & hyper-growth
start-ups. We have completed 100+ projects in Digital Health, Healthcare IT,
Medical Technology, Medical Devices & Pharma Services in the areas of
market assessments, due diligence, competitive intelligence, market sizing and
forecasting, pricing analysis & go-to-market strategy. Our methodology
includes rigorous secondary research combined with deep-dive interviews with
industry-leading CXO, VPs, and key demand/supply side decision-makers.
Contact:
Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
Comments
Post a Comment